Effects of Nicorandil Administration on Infarct Size in Patients With ST‐Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial

BACKGROUND: Nicorandil was reported to improve microvascular dysfunction and reduce reperfusion injury when administered before primary percutaneous coronary intervention. In this multicenter, prospective, randomized, double‐blind clinical trial (CHANGE [Effects of Nicorandil Administration on Infar...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Geng, Zhang, Ying, Dong, Wei, Jiang, Zi‐Chao, Li, Tao, Cheng, Liu‐Quan, Zou, Yu‐Ting, Jiang, Xiao‐Si, Zhou, Hao, A, Xin, Li, Ping, Chen, Mu‐Lei, Su, Xi, Tian, Jin‐Wen, Shi, Bei, Li, Zong‐Zhuang, Wu, Yan‐Qing, Li, Yong‐Jun, Chen, Yun‐Dai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683654/
https://www.ncbi.nlm.nih.gov/pubmed/36073634
http://dx.doi.org/10.1161/JAHA.122.026232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683654/
https://www.ncbi.nlm.nih.gov/pubmed/36073634
http://dx.doi.org/10.1161/JAHA.122.026232

Ejemplares similares